Anderson R G
Am J Physiol. 1982 Jul;243(1):E5-14. doi: 10.1152/ajpendo.1982.243.1.E5.
Low-density lipoprotein (LDL), the major plasma cholesterol transport protein, is taken up by cells through a receptor-mediated process. After internalization through specialized segments of the cell surface called coated pits, the LDL is degraded in the lysosome and the released cholesterol is used by cells to meet various metabolic needs. The discovery of the LDL receptor and the studies of its function have provided new insights into both the biochemical aspects of cholesterol metabolism and the cell biology of receptor-mediated endocytosis. Of paramount importance in all of these studies has been the availability of human cells that express one or more allelic mutations that affect the function of the LDL receptor. These mutations have been valuable for assessing normal receptor function. Just as important, these mutations have been used as a reference point in the development of various cytochemical and biochemical techniques for studying receptor activity.
低密度脂蛋白(LDL)是血浆中主要的胆固醇转运蛋白,细胞通过受体介导的过程摄取它。通过细胞表面称为被膜小窝的特殊区域内化后,LDL在溶酶体中降解,释放出的胆固醇被细胞利用以满足各种代谢需求。LDL受体的发现及其功能研究为胆固醇代谢的生化方面以及受体介导的内吞作用的细胞生物学提供了新的见解。在所有这些研究中至关重要的是存在表达一种或多种影响LDL受体功能的等位基因突变的人类细胞。这些突变对于评估正常受体功能很有价值。同样重要的是,这些突变已被用作开发各种用于研究受体活性的细胞化学和生化技术的参考点。